Genetic epidemiology of hypertension: An update on the African diaspora

Ethnicity and Disease

Volumn 13, Issue 2 SUPPL. 2, 2003, Pages

  Daniel, Harold I ^a   Rotimi, Charles N ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Africa; Descent; Genetics; Primary hypertension

Indexed keywords

ALDOSTERONE SYNTHASE; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; CANDESARTAN; IRBESARTAN;

ADULT; AFRICA; ANTIHYPERTENSIVE ACTIVITY; CALORIC INTAKE; CLINICAL TRIAL; DIET THERAPY; DISEASE CLASSIFICATION; DRUG RESPONSE; ENVIRONMENTAL FACTOR; ETHNOLOGY; GENETIC DISORDER; GENETIC EPIDEMIOLOGY; GENETIC PREDISPOSITION; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERTENSION; LIFESTYLE; NEGRO; PHENOTYPE; POPULATION DISTRIBUTION; POPULATION RESEARCH; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; URBANIZATION; CLASSIFICATION; DEMOGRAPHY; EPIDEMIOLOGY; GENETICS; HEALTH; PHARMACOGENETICS; SOCIAL ENVIRONMENT; STATISTICS; UNITED STATES;

AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; DEMOGRAPHY; EPIDEMIOLOGY, MOLECULAR; HUMANS; HYPERTENSION; PHARMACOGENETICS; PHENOTYPE; RISK FACTORS; SOCIAL ENVIRONMENT; UNITED STATES; WORLD HEALTH;

EID: 0042529405     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (169)

1. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999;17: 151-183.
2. McMahon FG. What is hypertension? In: McMahon FG, ed. Management of Essential Hypertension: The New Low-Dose Era. Mount Kisco, NY: Futura Publishing Company, Inc; 1984:1-35.
3. Pickering G. High blood pressure without evident cause: essential hypertension. BMJ. 1965;2:1021-1026.
4. Guidelines Subcommittee. 1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens. 1993;11:905-918.
5. Kannel WB. Hypertension and the risk of cardiovascular disease. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press; 1990:101-117.
6. Evans JG, Rose G. Hypertension. Br Med Bull. 1971;27:37-42.
7. JNC VI. November 1997. NIH Publication No. 98-4080.
8. Cooper R, Rotimi C, Ataman S, et al. The prevalence of hypertension in seven populations of West African origin. Am J Public Health. 1997;87:160-168.
9. Shaper AG, Ashby D, Pocock SJ. Blood pressure and hypertension in middle-aged British men. J Hypertens. 1988;6:367-374.
10. Lane D, Beevers DG, Lip GY. Ethnic differences in blood Pressure and the prevalence of hypertension in England. J Hum Hypertens. 2002;16(4):267-273.
11. Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart. 1997;78:555-563.
12. Sobngwi E, Mbanya JC, Unwin NC, et al. Physical activity and its relationship with obesity, hypertension, and diabetes in urban and rural Cameroon. Int J Obes Relat Metab Disord. 2002;26(7):1009-1016.
13. Kaufman JS, Durazo-Arvizu RA, Rotimi CN, McGee DL, Cooper RS. Obesity and hypertension prevalence in populations of African origin. The investigators of the International Collaborative Study on Hypertension in Blacks. Epidemiology. 1996;7: 398-405.
14. Gu D, Reynolds K, Wu X, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension. 2002;40(6): 920-927.
15. Gurav RB, Kartikeyan S, Jadhav BS. Biochemical profile of hypertensive individuals in an urban community. Indian J Med Sci. 2001;55(12):663-668.
16. Azizi F, Ghanbarian A, Madjid M, Rahmani M. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999-2000. J Hum Hypertens. 2002;16(5):305-312.
17. Hernandez-Hernanadez R, Armas-Padilla MC, Armas-Hernandez MJ, Velasco M. The prevalence of hypertension and the state of cardiovascular health in Venezuela and surrounding nations. Ethn Dis. 1998;8(3):398-405.
18. Yunis C, Krob HA. Status of health and prevalence of hypertension in Brazil. Ethn Dis. 1998;8(3):406-412.
19. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q. 1988;41: 155-168.
20. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension. 1995;26:60-69.
21. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management, and control in England: results from the health survey for England 1994. J Hypertens. 1998;16: 747-752.
22. Murray CJL, Lopez AD, eds. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Geneva: World Health Organization; 1996.
23. Williams GH. Hypertensive vascular disease. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 15th ed. Washington, DC: McGraw-Hill, Medical Publishing Division; 2001:1414-1430.
24. Lifton RP. Molecular genetics of human blood pressure variation. Science. 1996;272: 676-680.
25. Lifton RP, Dluhy RG, Powers M, et al. A chimaeric 11beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355:262-265.
26. Ulick S, Levine LS, Gunczler P, et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinal Metab. 1979;49:757-764.
27. Shimkets RA, Warnock DG, Bositis CM, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta unit of the epithelial sodium channel. Cell. 1994;79(3):407-414.
28. Strautnieks SS, Thompson RJ, Hanukoglu A, et al. Localization of pseudohypoaldosteronism genes to chromosome 16p12.2-13.11 and 12p13.1-pter by homozygosity mapping. Hum Mol Genet. 1996;5:293-299.
29. Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Phys. 1966;79:221-235.
30. Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12:24-30.
31. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brenner BM. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY. Raven Press, Ltd; 1990:81-100.
32. Harrap SB. Hypertension: genes versus environment. Lancet. 1994;344:169-171.
33. Williams RR, Hunt SC, Hasstedt SJ, et al. Are there interactions and relations between genetic and environmental factors predisposing to high blood pressure? Hypertension. 1991;18(suppl 1):I-129-I-137.
34. Cooper R, Rotimi C. Hypertension in populations of West African origin: is there a genetic predisposition? J Hypertens. 1994;12: 215-227.
35. Hamilton M, Pickering GW, Fraser-Robert JA, Sowry GSC. The etiology of hypertension 4: the role of inheritance. Clin Sci. 1954;13:273-304.
36. Ayman D. Heredity in arteriolar essential hypertension: a clinical study of the blood pressures of 1524 members of 277 families. Arch Intern Med. 1934;53:792-802.
37. Miall WE, Oldman PD. The heredity factor in arterial blood pressure. BMJ. 1963;1:75-80.
38. Annest JL, Sing CF, Biron P, Mougeau JG. Familial aggregation of blood pressure and weight in adoptive families I. Comparison of blood pressure and weight statistics among families with adopted, natural, or both natural and adopted children. Am J Epidemiol. 1979;110:479-491.
39. Annest JL, Sing CF, Biron P, Mougeau JG. Familial aggregation of blood pressure and weight in adoptive families II. Estimation of the relative contributions of genetic and common environmental factors to blood pressure correlations between family members. Am J Epidemiol. 1979;110:492-503.
40. Levine RS, Hennekens CH, Perry A, Cassady A, Gelbrand H, Jesse MJ. Genetic variance of blood pressure in infant twins. Am J Epidemiol. 1982;116:759-764.
41. Watt G. Design and interpretation of studies comparing individuals with and without a family history of high blood pressure. J Hypertens. 1986;4:1-7.
42. Feinleb M, Garrison RJ, Fabistz R, et al. The NHLBI twin study of cardiovascular disease risk factors, methodology, and summary of results. Am J Epidemiol. 1987;106: 284-295.
43. Rao RM, Reddy GP, Grim CE. Relative roles of genes and environment on blood pressure: twin studies in Madras, India. J Hum Hypertens. 1993;7:451-455.
44. Rotimi CN, Cooper RS, Cao G, et al. Maximum-likelihood generalized heritability estimate for blood pressure in Nigerian families. Hypertension. 1999;33:874-878.
45. Adeyemo AA, Omotade OO, Rotimi CN, Luke AH, Tayo BO, Cooper RS. Heritability of blood pressure in Nigerian families. J Hypertens. 2002;20(5):859-863.
46. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harboring the mouse Ren-2 gene. Nature. 1990;344: 541-544.
47. Kimura S, Mullins JJ, Bunnermann B, et al. High blood pressure in transgenic mice carrying the rat angiotensinogen. EMBO J. 1992;11:821-827.
48. Platt R. Heredity in hypertension. Lancet. 1963;i:899-904.
49. Pickering G. High blood pressure without evident cause: essential hypertension. BMJ. 1965;2:1021-1026.
50. Williams RR, Hunt SC, Hasstedt SJ, Hopkins PN, et al. Current knowledge regarding the genetics of human hypertension. J Hypertens. 1989;7(suppl 1):S8-S13.
51. Lander ES, Schork NJ. Genetic dissection of complex traits [published erratum appears in Science. Oct 21, 1994;266(5184):353] [review]. Science. 1994;265(5181):2037-2048.
52. Lifton RP. Molecular genetics of human blood pressure variation [review]. Science. 1996;272(5262):676-680.
53. Nkeh B, Tiago A, Candy GP, et al. Association between an atrial natriuretic peptide gene polymorphism and normal blood pressure in subjects of African ancestry. Cardiovasc J S Afr. 2002;13(3):97-101.
54. Williams SM, Addy JH, Phillips JA III, et al. Combinations of variations in multiple genes are associated with hypertension. Hypertension. 2000;36(1):2-6.
55. O'Byrne S, Caulfield M. Genetics of hypertension; therapeutic implications [review article]. Drugs. 1998;56:203-214.
56. Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann Med. 2002;34:1-8.
57. Kardia SL. Context-dependent genetic effects in hypertension. Curr Hypertens Rep. 2000;2(1):32-38.
58. Kruglyak L. Prospects of whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet. 1999;22:139-144.
59. Stamler J, Berkson DM, Dyer A, et al. Relationship of multiple variables to blood pressure: findings from four Chicago epidemiologic studies. In: Paul O, ed. Epidemiology and Control of Hypertension. Miami, Fla: Symposia Specialists; 1975:307-358.
60. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure: results for 24-hour urinary sodium and potassium excretion. BMJ. 1988;297:319-328.
61. Myers HF, McClure FH. Psychosocial factors in hypertension in Blacks: the case for an interactional perspective. In: Fray JCS, Douglas JG, eds. Pathophysiology of Hypertension in Blacks. New York, NY: Oxford University Press; 1993:90-106.
62. James S. Psychosocial and environmental factors in Blacks with hypertension. In: Hall WD, Shulman NB, Saunders E, eds. Hypertension in Blacks: Epidemiology, Pathophysiology and Treatment. Chicago, Ill: Year Book Medical Publishers; 1985:132-143.
63. Sherman JA, Strogatz DS, Wing SB, Ramsey D. Socioeconomic status, John Henryism, and hypertension in Blacks and Whites. Am J Epidemiol. 1987;126:664-673.
64. Sherwood A, May CW, Siegel WC, Blumerthal JA. Ethnic differences in hemodynamic responses to stress in hypertensive men and women. Am J Hypertens. 1995;8: 552-557.
65. Delehanty SG, Dimsdale JE, Mills P. Psychosocial correlates of reactivity in Black and White men. J Psychosom Res. 1991;35:451-460.
66. Kaufman JS, Tracy JA, Durazo-Arvizu RA, Cooper RS. Lifestyle and education effects on the prevalence of hypertension in populations of African origin: results from the International Collaborative Study on Hypertension in Blacks. Ann Epidemiol. 1997;7: 22-27.
67. Kaufman JS, Owoaje EE, James SA, Rotimi CN, Cooper RS. The determinants of hypertension in West Africa: contribution of anthropometric and dietary factors to urban-rural and socio-economic gradients. Am J Epidemiol. 1996;143:1203-1218.
68. Kaufman J, Barkey N. Hypertension in Africa: an overview of prevalence and causal risk factors. Ethn Dis. 1993;3(suppl):S83-S101.
69. Johnson JL, Heineman EF, Heiss G, Hames CG, Tyroler HA. Cardiovascular disease risk factors and mortality among Black women and White women aged 40-64 years in Evans County, Georgia. Am J Epidemiol. 1986;123:209-220.
70. Cooper RS, Rotimi CN, Kaufman JS, et al. Prevalence of NIDDM among populations of the African diaspora. Diabetes Care. 1997; 20(3):343-348.
71. Cruz-Coke R. Environmental factors and arterial blood pressure. Lancet. 1960;ii:885-886.
72. Beaglehole R, Eyles E, Salmond C, Prior I. Blood pressure in Tokelauan children in two contrasting environments. Am J Epidemiol. 1977;105:87-89.
73. Joseph JG, Prior IAM, Salmond CE, Stanley D. Elevation of systolic and diastolic blood pressure association with migration: the Tokelau Island migrant study. J Chronic Dis. 1983;36:507-516.
74. Marmot MG. Geography of blood pressure and hypertension. Br Med Bull. 1984;40: 380-386.
75. Poulter NR, Khaw KT, Hopwood BE, Mugambi M, et al. Determinants of blood pressure changes due to urbanization: a longitudinal study. J Hypertens. 1985;3(suppl 3): S375-S377.
76. O'Dea K. Cardiovascular disease risk factors in Australian aborigines. Clin Exp Pharmacol Physiol. 1991;18:85-88.
77. Mancilha-Carvalho JJ, Baruzzi RG, Howard PF, et al. Blood pressure in four remote populations in the Intersalt study. Hypertension. 1989;14:238-246.
78. Page LB, Damon A, Moellering RC. Antecedents of cardiovascular disease in six Solomon Island societies. Circulation. 1974;49: 1132-1146.
79. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? Analysis of observational data among populations. Analysis of observational data within populations. Analysis of data from trials of salt reduction. BMJ. 1991;302:811-824.
80. Kawasaki T, Delea CS, Bartter FC, Smith H. The effects of high sodium and low sodium intake on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med. 1978;64: 193-198.
81. Fujita T, Henry WL, Bartter FC, Lake CR, Delea CS. Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med. 1980;69:334-344.
82. Grim CE, Robinson M. Blood pressure variation in Blacks: genetic factors. Semin Nephrol. 1996;16:83-93.
83. Rydstedt LL, Williams GH, Hollenberg NK. Renal and endocrine response to saline infusion in essential hypertension. Hypertension. 1986;8:217-222.
84. Luft FC, Miller JZ, Weinberger MH, Christian JC, Skrabal F. Genetic influences on the response of dietary salt reduction, acute salt loading, or salt depletion in humans. J Cardiovasc Pharmacol. 1988;12(suppl 3):S49-S55.
85. Grim CE, Luft FC, Miller JZ, Brown PL, Gannon MA, Weinberger MH. Effects of sodium loading and depletion in normotensive first degree relatives of essential hypertensives. J Lab Clin Med. 1979;94:764-771.
86. Miller JZ, Weinberger MH, Christian JC, Daugherty SA. Familial resemblance in blood pressure response to sodium restriction. Am J Epidemiol. 1987;126:822-830.
87. Campese VM, Romoff MS, Levitan D, Saglikes Y, Friedler RM, Massry SG. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int. 1982;21:371-378.
88. Whelton PK, He J, Appel LJ, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. Oct 16, 2002;288(15):1882-1888.
89. Comstock GW. An epidemiologic study of blood pressure levels in a biracial community in the southeastern United States. Am J Hyg. 1957;65:271-315.
90. Hall WD, Ferrario CM, Moore MA, et al. Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci. 1997;313:195-206.
91. Halberstein RA. Blood pressure in the Caribbean. Hum Biol. 1999;71:659-684.
92. Seedat YK. Is the pathogenesis of hypertension different in Black patients? J Hum Hypertens. 1996;10(suppl 3):S35-S37.
93. Flackelmann KA. The African gene? Searching through history for the roots of Black hypertension. Science News. 1991;140:254-255.
94. Leary WE. Black hypertension may reflect other ills: outside factors may trigger genetic vulnerabilities. N Y Times. October 22, 1991; Medical Science Section:B6.
95. Grim CE, Wilson TW. Salt, slavery, and survival: physiological principles underlying the evolutionary hypothesis of salt-sensitivity hypertension in western hemisphere Blacks. In: Fray JCS, Douglas JG, eds. Pathophysiology of Hypertension in Blacks. New York, NY. Oxford University Press; 1993:25-49.
96. Weir MR, Hanes DS. Hypertension in African-Americans: a paradigm of metabolic disarray. Semin Nephrol. 1996;16:102-109.
97. Burroughs VJ, Maxey RW, Levy RA. Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment. J Natl Med Assoc. 2002;94(10): 1-26.
98. Steyn K, Fourie J, Lombard C, Katzenellenbogen J, Bourne L, Jooste P. Hypertension in the Black community of the Cape Peninsula South Africa. East Afr Med J. 1996; 73:758-763.
99. Beever DG, Prince JS. Hypertension: an emerging problem in tropical countries. Trans R Soc Trop Med Hyg. 1991;85:324-326.
100. Kumanyika S. Obesity in Black women. Epidemiol Rev. 1987;9:31-50.
101. Hargraves JL. The insurance gap and minority health care, 1997-2001. Track Rep. 2002;2:1-4.
102. Dawson G. The African-American male: brief insights on health, drugs, and incarceration, Part 1. J Natl Med Assoc. 1997; 89(9):580-584.
103. Darroch JE. Adolescent pregnancy trends and demographics. Curr Womens Health Rep. 2001;1(2):102-110.
104. Newman LA, Pollock RE, John-Thompson MC. Increasing the pool of academically oriented African-American medical and surgical oncologists. Cancer. 2003;97(suppl 1): 329-334.
105. Cooper RS, et al. Unpublished data from: The International Collaborative Study of Hypertension in Blacks - ICSHIB.
106. van Rooyen JM, Huisman HW, Eloff FC, et al. Cardiovascular reactivity in Black South-African males of different age groups: the influence of urbanization. Ethn Dis. 2002;12(1):69-75.
107. Seedat K, Seedat MA, Hackland DBT. Biosocial factors and hypertension in urban and rural Zulus. S Afr Med J. 1982;61:999-1002.
108. Poulter NR, Khaw KT, Hopwood BE, et al. The Kenyan Luo migration study: observations on the initiation of rise in blood pressure. BMJ. 1990;300(6730):967-972.
109. Edwards R, Unwin N, Mugusi F, et al. Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens. 2000;18(2):145-152.
110. Mtabaji JP, Nara Y, Yamori Y. The cardiac study in Tanzania: salt intake in the causation and treatment of hypertension. J Hum Hypertens. 1990;4:80-81.
111. Lore W. Epidemiology of cardiovascular disease in Africa with special reference to Kenya: an overview. East Afr Med J. 1993;70: 357-368.
112. Mugambi M, Little MA. Blood pressure in nomadic Turkana pastoralists. East Afr Med J. 1983;60:863-870.
113. van der Sande MAB, Milligan PJM, Nyan OA, et al. Blood pressure patterns and cardiovascular risk factors in rural and urban Gambian communities. J Hum Hypertens. 2000;14:489-496.
114. Nair P, Nyamphisi M, Yarnell JW. Lack of differences in blood pressure between the urban and rural population in Lesotho, Africa. Cent Afr J Med. 1994;40:278-281.
115. M'Buyamba-Kabangu JR, Fagard R, Staessen J, Lijnen R, Amery A. Correlates to blood pressure in rural and urban Zaire. J Hypertens. 1987;5:371-375.
116. Olatunbosun ST, Ojo PO, Fineberg NS, Bella AF. Prevalence of diabetes mellitus and impaired glucose tolerance in a group of urban adults in Nigerian. J Natl Med Assoc. 1998;90:293-301.
117. Levitt NS, Katzenellenbogen JM, Bradshaw D, Hoffman MN, Bonnici F. Prevalence and identification of risk factors for NIDDM in urban Africans in Cape Town, South Africa. Diabetes Care. 1993;16:601-607.
118. Daniel HI, Munroe PB, Lawson M, Fogarty P, Kamdar SM, Caulfield M. Investigation of the renin gene as a putative locus for essential hypertension (EH) in Vincentian African Caribbeans. J Hum Hypertens. 1994;8: 609-610.
119. Naftilan AJ, Williams RR, Burt D, et al. A lack of genetic linkage of renin gene restriction fragment length polymorphism with hypertension. Hypertension. 1989;14:614-618.
120. Soubrier F, Jeunemaitre X, Rigat B, Houot A, Cambien F, Corvol P. Similar frequencies of renin gene restriction fragment length polymorphism in hypertensive and normotensive subjects. Hypertension. 1990;16:712-717.
121. Kamdar S, Daniel H, Fogarty P, Lawson M, Munroe P, Caulfield M. ACE insertion/deletion (I/D) polymorphism in Vincentian African Caribbeans with essential hypertension. J Hum Hypertens. 1994;8:611.
122. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the ACE locus and human essential hypertension. Nat Genet. 1992;1:72-75.
123. Schmidt S, van Hooft IMS, Grobbee DE, Ganten D, Ritz E. Polymorphism of the angiotensin 1 converting enzyme gene is apparently not related to high blood pressure. J Hypertens. 1993;11:345-348.
124. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin 1 converting enzyme gene accounting for half of the variance of serum levels. J Clin Invest. 1990;86:1343-1346.
125. Harrap SB, Davidson HR, Connor JM, et al. The angiotensin 1 converting enzyme gene and predisposition to high blood pressure. Hypertension. 1993;21:455-460.
126. Cambien F, Poirier O, Lecerf O, et al. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
127. Marian AJ, Yu Q, Workman R, Greve G, Robert R. ACE polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 1993;342:1085-1086.
128. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
129. Caulfield M, Lavender P, Newell-Price J, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest. 1995;96: 687-692.
130. Rotimi CN, Cooper RS, Ugunbiyi O, et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation. 1997; 95:2348-2350.
131. Rutledge DR, Sun Y, Ross EA. Polymorphisms within the atrial natriuretic peptide gene in essential hypertension. J Hypertens. 1995;13:953-955.
132. Barley J, Carter ND, Cruickshank JK, et al. Renin and atrial natriuretic factor restriction fragment length polymorphisms: association with ethnicity and blood pressure. J Hypertens. 1991;9:993-996.
133. Daniel HI, Munroe PB, Kamdar SM, et al. The atrial natriuretic peptide gene and essential hypertension in African Caribbeans from St Vincent and the Grenadines. J Hum Hypertens. 1997;11:113-117.
134. 2 receptor gene in hypertensive African Americans. Am J Hypertens. 2000;13:1268-1273.
135. Lifton R. Molecular genetics of human blood pressure variation. Science. 1996;272: 676-680.
136. Svetkey LP, Timmons PZ, Emovon O, Anderson NB, Preis L, Chen YT. Association of hypertension with beta-2 and alpha-2c adrenergic receptor genotype. Hypertension. 1996;27:1210-1215.
137. Mills PJ, Dimsdale JE, Ziegler MG, Nelesen RA. Racial differences in epinephrine and beta-2 adrenergic receptors. Hypertension. 1995;25:88-91.
138. 2-Adrenergic receptor gene polymorphism and hypertension in Blacks. Am J Hypertens. 1995;8:390-394.
139. Dong Y, Zhu H, Sagnella GA, Carter ND, Cook DG, Cappuccio FP. Association between the C825T polymorphism of the G protein beta-3 subunit gene and hypertension in Blacks. Hypertension. 1999;34:1193-1196.
140. Siffert W, Rosskopf D, Siffert G, et al. Association of human G-protein beta-3 subunit variant with hypertension. Nat Genet. 1998;18:45-48.
141. Beige J, Hohenbleicher H, Distler A, Sharma AM. G-protein beta-3 subunit C825T variant and ambulatory blood pressure in essential hypertension. Hypertension. 1999;33: 1049-1051.
142. Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR, Morris BJ. G-protein beta-3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension. 1998;32:1094-1097.
143. Brand E, Hermann S-M, Nicaud V, et al. The 825C/T polymorphism of the G-protein subunit beta-3 is not related to hypertension. Hypertension. 1999;33:1175-1178.
144. Gonzalez-Nunez D, Giner V, Bragulat E, Coca A, de la Sierra A, Poch E. Absence of an association between the C825T polymorphism of the G-protein beta-3 subunit and salt-sensitivity in essential arterial hypertension. Nefrologia. 2001;21:355-361.
145. Baker EH, Dong YB, Sagnella GA, et al. Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in Black people residing in London. Lancet. 1998;351:1388-1392.
146. Baker EH, Ireson NJ, Dong YB, Blackwood A, Sagnella GA, MacGregor GA. Increased sodium channel activity in Black people with the T594M epithelial channel mutation. Hypertension. 1998;32:793.
147. Dong YB, Zhu HB, Baker EH, et al. T594M and G442V polymorphism of the sodium channel beta subunit and hypertension in a Black population. J Hum Hypertens. 2001;15:425-430.
148. Dong YB, Plange-Rhule J, Owusu I, et al. T594M mutations of the beta-subunit of the epithelial sodium channel in Ghanaian populations from Kumasi and London and a possible association with hypertension. Genet Testing. 2002;6(1):63-65.
149. + channel. Cell. 1995;83:969-978.
150. Munroe PB, Strautnieks SS, Farrall M, et al. Absence of linkage of the epithelial sodium channel to hypertension in Black Caribbeans. Am J Hypertens. 1998;11:942-945.
151. Grim CE. On slavery, salt, and the higher blood pressure among African Americans [abstract]. Clin Res. 1988;36:426A.
152. Poston WS, Pavlik VN, Hyman DJ, et al. Genetic bottlenecks, perceived racism, and hypertension risk among African Americans and first generation African immigrants. J Hum Hypertens. 2001;15(5):341-351.
153. Watson B, Bergman SM, Myracle A, Callen DF, Acton RT, Warnock DG. Genetic association of 11 â-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in Blacks. Hypertension. 1996;28:478-482.
154. White PC. Inherited forms of mineralocorticoid hypertension. Hypertension. 1996; 28(6):927-936.
155. Cooper RS, Luke A, Zhu X, et al. Genome scan among Nigerians linking blood pressure to chromosome 2, 3, and 9. Hypertension. 2002;40(5):629-633.
156. Rice T, Rankinen T, Chagnon YC, et al. Genomewide linkage scan of resting blood pressure. HERITAGE family study. Hypertension. 2002;39:1037-1043.
157. Wilk JB, Myers RH, Zhang Y, et al. Evidence for a gene influencing heart rate on chromosome 4 among hypertensives. Hum Genet. 2002;111:207-213.
158. DeWan AT, Arnett DK, Atwood LD, et al. A genome scan for renal function among hypertensives: the HyperGEN study. Am J Hum Genet. 2001;68(1):136-144.
159. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med. 1982;306(21):1276-1279.
160. Blythe WB, Maddux FW. Hypertension as a causative diagnosis of patients entering end-stage disease programs in the United States from 1980 to 1986. Am J Kidney Dis. 1991;18(1):33-37.
161. Kurland L, Melhus H, Karlsson J, et al. Aldostrone synthase (CYP11B2)-344C/T polymorphism (within the promoter region of the gene) is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. Am J Hypertens. 2002;15(5):389-393.
162. Ortlepp JR, Hanrath P, Mevissen V, Kiel G, Borggrefe M, Hoffmann R. Variants of the CYP11B2 gene predict response to therapy with candesartan. Eur J Pharmacol. 2002; 445:151-152.
163. Baker EH, Duggal A, Dong Y, et al. Amiloride, a specific drug for hypertension in Black people with T594M variant? Hypertension. 2002;40(1):13-17.
164. Pratt JH, Ambrosius WT, Agarwal R, Eckert GJ, Newman S. Racial differences in the activity of the amiloride-sensitive epithelial sodium channel. Hypertension. 2002;40(6): 903-908.
165. News. The new word in designer drugs. BMJ. 1998;316:1930.
166. Adeyemo AA, Prewitt TE, Luke A, et al. The feasibility of implementing a dietary sodium reduction intervention among free-living normotensive individuals in southwest Nigeria. Ethn Dis. 2002;12(2):207-212.
167. Zabsonre P, Sanou G, Avanzini F, Tognoni G. Knowledge and perception of cardiovascular risk factors in Africa south of the Sahara. Arch Mal Coeur Vaiss. 2002;95(1):23-28.
168. Coatney GR. Pitfalls in a discovery: the chronicle of chloroquine. Am J Trop Med Hyg. 1963;12:121-128.
169. Daniel HI, Molta NB. Efficacy of chloroquine in the treatment of malaria in children under five years in Baissa (Gongola State, Nigeria). Ann Trop Med Parasitol. 1989; 83(4):331-338.